Press Releases

January 15, 2020

ProMIS Neurosciences Appoints Dr. José Luis Molinuevo to its Scientific Advisory Board 

January 9, 2020

ProMIS Neurosciences to present at Sachs 3rd Annual Neuroscience Innovation Forum

January 8, 2020

ProMIS Neurosciences issues Chairman’s Update detailing positive outlook for Alzheimer’s disease therapy, pipeline in 2020

Press Archives

In the News

December 12, 2019

STAT – Listen: Biogen’s big reveal, hot takes on Alzheimer’s, & the science of one-eyed sheep

December 12, 2019

Being Patient – Biogen Reports Drug Effective in Slowing Alzheimer’s Disease: ‘A Milestone Achievement

December 12, 2019

The Medicine Maker – Getting on Target for Alzheimer’s Biogen revitalizes hope for Alzheimer’s therapy, but their work highlights why we still need greater selectivity

News Archives

Presentations

November 6, 2019

ProMIS Neurosciences: “Best in Class” therapy for misfolded protein diseases, based on a proprietary discovery platform

September 10, 2019

Executive Chairman Gene William’s Presentation at the HC Wainwright Investor Conference

August 12, 2019

CSO Neil Cashman’s overview of ProMIS’ unique capability to selectively target toxic, misfolded proteins that are root causes of neurodegenerative diseases

Presentations Archives

Videos

November 6, 2019

ProMIS Neurosciences: “Best in Class” therapy for misfolded protein diseases, based on a proprietary discovery platform

August 6, 2019

Dr. James Kupiec’s update from AAIC 2019: Demonstrating Early Proof-of-Concept with Biomarkers and Focused Patient Populations

July 18, 2019

ProMIS Neurosciences Highlights Data for PMN310 at AAIC 2019 

Video Archives